Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018; New Report Launched
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 report provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for type I diabetes, type II diabetes, hyperinsulinemia and hyperglycemia, and features dormant and discontinued products.
View full press release